These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24535736)

  • 1. Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
    Sunaga F; Arai S; Itoh S; Taharaguchi S
    Parasitol Res; 2014 May; 113(5):1681-6. PubMed ID: 24535736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence attenuation of Babesia gibsoni by serial passages in vitro and assessment of the protection provided by the immunization against the passaged isolate in dogs.
    Sunaga F; Taharaguchi S; Arai S; Itoh S; Kanno Y
    Vet Parasitol; 2013 Nov; 197(3-4):565-70. PubMed ID: 23773722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture-derived Babesia orientalis exoantigens used as a vaccine against buffalo babesiosis.
    Zhao JL; Liu ZL; Yao BA; Ma LH
    Parasitol Res; 2002 May; 88(13 Suppl 1):S38-40. PubMed ID: 12051606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs.
    Cao S; Mousa AA; Aboge GO; Kamyingkird K; Zhou M; Moumouni PF; Terkawi MA; Masatani T; Nishikawa Y; Suzuki H; Fukumoto S; Xuan X
    Acta Parasitol; 2013 Dec; 58(4):619-23. PubMed ID: 24338330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
    Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
    Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection.
    Valentin A; Precigout E; L'Hostis M; Carcy B; Gorenflot A; Schrevel J
    Infect Immun; 1993 Feb; 61(2):734-41. PubMed ID: 8423099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs.
    Fukumoto S; Tamaki Y; Shirafuji H; Harakawa S; Suzuki H; Xuan X
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):557-9. PubMed ID: 15817768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice.
    Terkawi MA; Jia H; Zhou J; Lee EG; Igarashi I; Fujisaki K; Nishikawa Y; Xuan X
    Vaccine; 2007 Mar; 25(11):2027-35. PubMed ID: 17229504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
    Schetters TH; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
    Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells.
    Fukumoto S; Xuan X; Takabatake N; Igarashi I; Sugimoto C; Fujisaki K; Nagasawa H; Mikami T; Suzuki H
    Infect Immun; 2004 Mar; 72(3):1795-8. PubMed ID: 14977989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Babesia gibsoni 12-kDa protein as a potential antigen for the serodiagnosis.
    Goo YK; Jia H; Aboge GO; Terkawi MA; Lee EG; Yamagishi J; Nishikawa Y; Jang HK; Sunaga F; Namikawa K; Fujisaki K; Xuan X
    Parasitol Int; 2009 Mar; 58(1):55-60. PubMed ID: 19000776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a practical immunochromatographic test with recombinant P50 for the diagnosis of Babesia gibsoni infection in dogs.
    Verdida RA; Xuan X; Fukumoto S; Huang X; Zhou J; Igarashi I; Claveria FG; Nagasawa H
    Parasitology; 2005 Dec; 131(Pt 6):769-74. PubMed ID: 16336730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of antibodies against Babesia gibsoni detected by ELISA with recombinant P50.
    Miyama T; Inokuma H; Itamoto K; Okuda M; Verdida RA; Xuan X
    J Vet Med Sci; 2006 Dec; 68(12):1371-3. PubMed ID: 17213713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to South African Babesia canis and the development of a preliminary vaccine.
    Lewis BD; Penzhorn BL; López Rebollar LM
    J S Afr Vet Assoc; 1995 Jun; 66(2):61-5. PubMed ID: 8544162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis.
    Schetters TP; Scholtes NC; Kleuskens JA; Bos HJ
    Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.